DCN Diagnostics(@DCNDiagnostics) 's Twitter Profile Photo

Watch Dr. Kristin Cederquist's insightful session on the roles of thermodynamics & kinetics in design. 🔬💡

Optimize your with expert insights from .

Full video: hubs.ly/Q02twmjp0

Watch Dr. Kristin Cederquist's insightful #ALFC2024 session on the roles of thermodynamics & kinetics in #LFA design. 🔬💡

Optimize your #LateralFlow #Assays with expert insights from #DCNDx.

Full video: hubs.ly/Q02twmjp0

#Diagnostics #IVD #SharingKnowledge
account_circle
DCN Diagnostics(@DCNDiagnostics) 's Twitter Profile Photo

🦠 In our recent article, our VP of Clinical Research delves into the FDA's recent decision to reclassify certain from Class III to Class II.
hubs.ly/Q02ryyYN0

🦠 In our recent #ExpertInsights article, our VP of Clinical Research delves into the FDA's recent decision to reclassify certain #infectiousdisease #IVDs from Class III to Class II. 
hubs.ly/Q02ryyYN0

#DCNDx #FDA #Regulatory #ClinicalStudies #Diagnostics
account_circle
DCN Diagnostics(@DCNDiagnostics) 's Twitter Profile Photo

🦠 In our recent article, our VP of Clinical Research delves into the FDA's recent decision to reclassify certain from Class III to Class II.
hubs.ly/Q02ryqNq0

🦠 In our recent #ExpertInsights article, our VP of Clinical Research delves into the FDA's recent decision to reclassify certain #infectiousdisease #IVDs from Class III to Class II. 
hubs.ly/Q02ryqNq0

#DCNDx #FDA #Regulatory #ClinicalStudies #Diagnostics
account_circle
DCN Diagnostics(@DCNDiagnostics) 's Twitter Profile Photo

Watch Dr. Kristin Cederquist's insightful session on the roles of thermodynamics & kinetics in design. 🔬💡

Optimize your with expert insights from .

Full video: hubs.ly/Q02tws1B0

Watch Dr. Kristin Cederquist's insightful #ALFC2024 session on the roles of thermodynamics & kinetics in #LFA design. 🔬💡

Optimize your #LateralFlow #Assays with expert insights from #DCNDx.

Full video: hubs.ly/Q02tws1B0

#Diagnostics #IVD #SharingKnowledge
account_circle
DCN Diagnostics(@DCNDiagnostics) 's Twitter Profile Photo

🦠 In our recent article, our VP of Clinical Research delves into the FDA's recent decision to reclassify certain from Class III to Class II.
hubs.ly/Q02ryrRM0

🦠 In our recent #ExpertInsights article, our VP of Clinical Research delves into the FDA's recent decision to reclassify certain #infectiousdisease #IVDs from Class III to Class II. 
hubs.ly/Q02ryrRM0

#DCNDx #FDA #Regulatory #ClinicalStudies #Diagnostics
account_circle